🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Lots of buzz re: PSMA-PET, LuPSMA and biomarkers at #ASCO22.. Our work of serial CTC profiling of PRINCE trial (LuPSMA+pembro): assoc with PET metrics and early change/clearance of PSMA+ CTCs may forecast outcome on LuPSMA 1/2 Michael Hofman A/Prof. Shahneen Sandhu Peter Mac Research Epic Sciences │ The Power of Clarity

Did you happen to see Epic Sciences │ The Power of Clarity featured on the Nasdaq MarketSite in NY Time Square last week? It’s exciting to have world-class investors that are committed to truly partnering with Epic and is a privilege to work with them to invest in improving care for cancer patients.

“We are continuing to innovate testing for both the research and clinical markets”- Lloyd Sanders, president and CEO of Epic Sciences │ The Power of Clarity – as quoted in last week’s San Diego Business Journal article covering Epic’s recent #funding announcement. sdbj.com/news/2022/jun/… #liquidbiopsy #diagnostics

Congratulations, Epic Sciences │ The Power of Clarity! The biotech company has raised $43M to advance its liquid biopsy offerings 🥳 Its #SDlifechanging tests are intended to be used when tissue biopsy is inaccessible or infeasible. P.S. They're hiring 👀 epicsciences.applytojob.com/apply

Statistician Glenn Heller Memorial Sloan Kettering Cancer Center; Ronald Chen, Andy Laccetti MD, MS, and Gina Mazza Mayo Clinic Comprehensive Cancer Center for health outcomes; Misha Beltran from the correlatives committee, Decipher by Veracyte and Epic Sciences │ The Power of Clarity for supporting correlative studies and everyone else who got this running!

We look forward to connecting with our partners at the World ADC Conference in San Diego, September 6-9! These are exciting times to be working with partners developing new ADCs that will benefit patients! #WorldADC #biomarkers #cancer #drugdevelopment

Pleased to share our latest analysis of PROPHECY showing the independent prognostic importance of PSMA+ CTCs in men with mCRPC treated with Abi/Enza. Sets stage for testing in context of PSMA therapy DCI Center for Prostate & Urologic Cancers Epic Sciences │ The Power of Clarity Emmanuel Antonarakis The PCCTC Dan George

President & CEO of Epic Sciences supporting our 2022 Komen San Diego More Than Pink Walk by serving on the Susan G. Komen Executive Leadership Committee. bit.ly/3QFGs18

Liquid biopsies offer the opportunity to gather information about each patient’s evolving cancer more frequently. Check out "The Impact of PSMA+ CTCs in Men with mCRPC" presented at #ESMO2022. Visit our website to learn more: lnkd.in/gigPRs9 #prostatecancer #liquidbiopsy

Great collaboration at the recent #WorldADC conference in San Diego as antibody-drug conjugates gain momentum! CTC-based #liquidbiopsy HER2, TROP2, PSMA, HER3, & Claudin18.2 protein expression can add insights for #ADC development. To learn more, email us at [email protected]

Hiding in Plain Sight: Early, nano-sized signs of breast cancer detected by liquid biopsy cancercommunity.nature.com/posts/hiding-i… Michelson Medical Research Foundation USC Michelson CSI-Cancer BLOODPAC Epic Sciences │ The Power of Clarity @NCI_CSSI

DefineMBC - a new liquid biopsy test from Epic Sciences │ The Power of Clarity for those with #metastaticbreastcancer!! Wed 10/12 on #BreastFriendsCancerSupportNetwork Listen lnkd.in/gAJakseA or watch lnkd.in/gQbcJnYt #MBC #liquidbiopsy INeverLikedPink

Listen to the latest Breast Friends podcast to learn about the numerous obstacles that still remain for patients and clinicians who are battling metastatic breast cancer.  Tune in to the Breast Friends YouTube Channel here: lnkd.in/gQbcJnYt

Epic Sciences will be participating in #PODC2022 in Chicago on October 19th & 20th. We look forward to meeting with collaborators and new potential partners as we all work together to improve care for patients with #cancer. precisionmedicineleaderssummit.com/precision-onco… #oncology #clinicaltrials

We are excited to announce William J. Kullback as CFO of Epic Sciences. Bill’s experience navigating companies through successful expansion and his background in mergers & acquisitions will be critical as Epic moves into the next phase of company growth. epicsciences.com/press-releases…

Want to learn more about how complementary cell-based phenotypic and genomic analysis can inform your #drugdevelopment programs? We look forward to seeing you at SABCS 12/6 - 12/10 Learn more by emailing us at [email protected] #liquidbiopsy #sabcs2022 #breastcancer

Just a little sneak peak of our booth set up at SABCS. The Epic Sciences Biopharma team looks forward to discussing how our technology can inform your clinical development efforts. Visit us 12/7 to 12/9 from 10-5 at booth #529. We look forward to seeing you there.